Agrocybe chaxingu polysaccharide prevent inflammation through the inhibition of COX-2 and NO production

BMB Reports

Volumn 42, Issue 12, 2009, Pages 794-799

  Lee, Byung Ryong ^a   Kim, So Young ^a   Kim, Dae Won ^a   An, Jae Jin ^a   Song, Ha Yong ^a   Yoo, Ki Yeon ^b   Kang, Tae Cheon ^b   Won, Moo Ho ^b   Lee, Kwang Jae ^c   Kim, Kyung Hee ^c   Joo, Jin Ho ^d   Ham, Hun Ju ^d   Hur, Jang Hyun ^d   Cho, Sung Woo ^e   Han, Kyu Hyung ^a   Lee, Kil Soo ^a   Park, Jinseu ^a   Choi, Soo Young ^a   Eum, Won Sik ^a  

^a Division of Life Sciences   (South Korea)

^b Hallym University   (South Korea)

^c Gangwon Agricultural Research and Extention Services   (South Korea)

^d Kangwon National University   (South Korea)

^e University of Ulsan College of Medicine   (South Korea)

Author keywords

Agrocybe chaxingu; Cyclooxygenase 2 (COX 2); Lipopolysaccaride (LPS); Nitric oxide (NO); Glucan

Indexed keywords

AGROCYBE CHAXINGU; MURINAE; MUS;

EID: 77949493076     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2009.42.12.794     Document Type: Article

References (39)

1. Yu, H. H., Wu, F. L., Lin, S. E. and Shen, L. J. (2008) Recombinant arginine deiminase reduces inducible nitric oxide synthase iNOS-mediated neurotoxicity in a coculture of neurons and microglia. J. Neurosci. Res. 86, 2963-2972.
2. Colton, C. A., Vitek, M. P., Wink, D. A., Xu, Q., Cantillana, V., Previti, M. L., van Nostrand, W. E., Weinberg, J. B. and Dawson, H. (2006) NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 103, 12867-12872.
3. Dawson, V. L., Kizushi, V. M., Huang, P. L., Snyder, S. H. and Dawson, T. M. (1996) Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J. Neurosci. 16, 2479-2487.
4. Good, P. F., Hsu, A., Werner, P., Perl, D. P. and Olanow, C. W. (1998) Protein nitration in Parkinson's disease. J. Neuropathol. Exp. Neurol. 57, 338-342.
5. Huang, Z., Huang, P. L., Panahian, N., Dalkara, T., Fishman M. C. and Moskowitz, M. A. (1994) Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265, 1883-1885.
6. Iadecola, C., Zhang, F., Casey, R., Nagayama, M. and Ross, M. E. (1997) Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J. Neurosci. 17, 9157-9164.
7. Martin, L. J., Liu, Z., Chen, K., Price, A. C., Pan, Y., Swaby, J. A. and Golden, W. C. (2007) Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanism of mitochondriopathy and cell death. J. Comp. Neurol. 500, 20-46.
8. Amin, A. R., Attur, M. and Abramson, S. B. (1999) Nitric oxide synthase and cyclooxygenases: distribution, regulation, and intervention in arthritis. Curr. Opin. Rheumatol. 11, 202-209.
9. Tilley, S. L., Coffman, T. M. and Koller, B. A. (2001) Mixed message: gene: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Invest. 107, 191-195.
10. Smith, W. L. and Dewit, D. L. (1990) Prostaglandin endoperoxide H synthase-1 and -2. Adv. Immunol. 62, 167-215.
11. Carey, M. A., Germolec, D. R., Langenbach, R. and Zeldin, D. C. (2003) Cyclooxygenase enzymes in allergic inflammation and asthma. Prostaglandins Leukot. Essent. Fatty Acids 69, 157-162.
12. Vancheri, C., Mastruzzo, C., Sortino, M. A. and Crimi, N. (2004) The lung as a privileged site for the beneficial actions of PEG2. Trends Immunol. 25, 40-46.
13. Rietschel, E. T., Kirikae, T., Schade, F. U., Mamat, U., Schmidt, G., Loppnow, H., Ulmer, A. J., Zahringer, U., Seydel, U. and Di Padova, F. (1994) Bacterial endotoxin: molecular relationships and structure to activity and function. FASEB J. 8, 217-225.
14. Adams, D. O. and Hamilton, T. A. (1984) The cell biology of macrophage activation. Annu. Rev. Immunol. 2, 283-318.
15. Morrison, D. C. and Ryan, J. L. (1987) Endotoxins and disease mechanisms. Annu. Rev. Med. 38, 417-432.
16. DiGiovanni, J. (1992) Multistage carcinogenesis in mouse skin. Pharmacol. Ther. 54, 63-128.
17. Slaga, T. J., Fischer, S. M., Weeks, C. E., Klein-Szanto, A. J. and Reiners, J. (1982) Studies on the mechanisms involved in multistage carcinogenesis in mouse skin. J. Cell Biochem. 18, 99-119.
18. Furstenberger, G., Berry, D. L., Sorg, B. and Marks, F. (1981) Skin tumor promotion by phorbol esters is a two-stage process. Proc. Natl. Acad. Sci. U.S.A. 78, 7722-7726.
19. Furstenberger, G., Sorg, B. and Marks, F. (1983) Tumor promotion by phorbol esters in skin: evidence for a memory effect. Science 220, 89-91.
20. Song, H. Y., Lee, J. A., Ju, S. M., Yoo, K. Y., Won, M. H., Kwon, H. J., Eum, W. S., Jang, S. H., Choi, S. Y. and Park, J. (2008) Topical transduction of superoxide dismutase mediated by HIV-1 Tat protein transduction domain ameliorates 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation in mice. Biochem. Pharmacol. 75, 1348-1357.
21. Chung, W. Y., Park, J. H., Kim, M. J., Kim, H. O., Hwang, J. K., Lee, S. K. and Park, K. K. (2007) Xanthorrhizol inhibits 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced acute inflammation and two-stage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogen-activated protein kinases and/or the nuclear factor-kB. Carcinogenesis 28, 1224-1231.
22. Ho, Y. S., Lai, C. S., Liu, H. I., Ho, S. Y., Tai, C., Pan, M. H. and Wang, Y. J. (2007) Dihydrolipoic acid inhibits skin tomor promotion through anti-inflammation and anti-oxidation. Biochem. Pharmacol. 73, 1786-1795.
23. Surh, Y. J., Chun, K. S., Cha, H. H., Han, S. S., Keum, Y. S., Park, K. K. and Lee, S. S. (2001) Molecular mechanisms underlying chemoprventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat. Res. 480-481, 243-268.
24. Yoon, S. Y., Eo, S. K., Kim, Y. S., Lee, S. K. and Han, S. S. (1994) Antimicrobial activity of Garnoderma lucidum extracts alone and in combination with some antibiotics. Arch. Pharm. Res. 17, 438-442.
25. Wang, S. Y., Hsu, M. L., Hsu, H. C., Tzeng, C. H., Lee, S. S., Shiao, M. S. and Ho, C. K. (1997) The anti-tumor effect of Garnoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int. J. Cancer 70, 699-705.
26. Eo, S. K., Kim, Y. S., Lee, C. K. and Han, S. S. (2000) Possible mode of antiviral activity of acidic protein bound polysaccharides isolated from Ganoderma lucidum on herpes simplex viruses. J. Ethnopharmacol. 72, 475-481.
27. Lin, J. M., Lin, C. C., Chen, M. F., Ujiie, T. and Takada, A. (1995) Radical scavenger and antihepatotoxic activity of Garnoderma formosanum, Garnoderma lucidum and Garnoderma neo-japonicum. J. Ethnopharmacol. 47, 33-41.
28. Lin, J. M., Lin, C. C., Chiu, H. F., Yang, J. J. and Lee, S. C. (1993) Evaluation of the anti-inflammatory and liver-protective effects of anoectohilus formosanus, garnoderma lucidum and gynostemma pentaphyllum in rats. Am. J. Chin. Med. 21, 59-69.
29. Prescott, S. M. and Fitzpatrick, F. A. (2000) Cyclooxygenase-2 and carcinogenesis. Biochim. Biophys. Acta 1470, M69-78.
30. Chun, K. S., Cha, H. H., Shin, J. W., Na, H. K., Park, K. K., Chung, W. Y. and Surh, Y. J. (2004) Nitric oxide induces expression of cyclooxygenase-2 in mouse skin through activation of NF-kappa B. Carcinogenesis 25, 445-454.
31. Chun, K. S., Keum, Y. S., Han, S. S., Song, Y. S., Kim, S. H. and Surh, Y. J. (2003) Curcumin inhibits phorbol ester-induced expression of cyclooxgenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappa B activation. Carcinogenesis 24, 1515-1524.
32. Choi, M. A., Kim, S. H., Chung, W. Y., Hwang, J. K. and Park, K. K. (2005) Xanthorrhizol, a natural sesquiterpenoid from Curcuma xanthorrhiza, has an anti-metastatic potential in experimental mouse lung metastasis model. Biochem. Biophys. Res. Commun. 326, 210-217.
33. Stanely, P. L., Steiner, S., Havens, M. and Tramposch, K. M. (1991) Mouse skin inflammation induced by multiple topical applications of 12-O-tetradecanoylphorbol-13-acetate. Skin Pharmacol. 4, 262-271.
34. Pastore, S., Mascia, F., Mariotti, F., Dattilo, C., Mariani, V. and Girolomoni, G. (2005) ERK1/2 regulates epidermal chemokine expression and skin inflammation. J. Immunol. 174, 5047-5056.
35. Steeber, D. A., Tang, M. L., Green, N. E., Zhang, X. Q., Sloane, J. E. and Tedder, T. F. (1999) Leukocyte entry into sites of inflammation requires overlapping interactions between the L-selectin and ICAM-1 pathways. J. Immunol. 163, 2176-2186.
36. Kim, D. W., Kim, S. Y., Lee, S. H., Lee, Y. P., Lee, M. J., Jeong, M. S., Jang, S. H., Park, J., Lee, K. S., Kang, T. C., Won, M. H., Cho, S. W., Kwon, O. S., Eum, W. S. and Choi, S. Y. (2008) Protein transduction of an antioxidant enzyme: subcellular localization of superoxide dismutase fusion protein in cells. BMB Reports 4, 170-175.
37. Misko, T. P., Schilling, R. J., Salvemini, D., Moore, W. M. and Currie, M. G. (1993) A fluorometric assay for the measurement of nitrite in biological samples. Anal. Biochem. 214, 11-16.
38. Shin, J., Gu, C., Kim, J. and Park, S. (2008) Transient activation of the MAP kinase signaling pathway by the forward signaling of EphA4 in PC12 cells. BMB Reports 41, 479-484.
39. Zhang, S. Y., Park, K. W., Oh, S., Cho, H. J., Cho, H. J., Park, J. S., Cho, Y. S., Koo, B. K., Chae, I. H., Choi, D. J., Kim, H. S. and Lee, M. M. (2005) NF-kappaB decoy potentiates the effects of radiation on vascular smooth muscle cell by enhancing apoptosis. Exp. Mol. Med. 37, 18-26.